Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Eva Hametner"'
Autor:
Lukas Mayer-Suess, Michael Knoflach, Andreas Pircher, Stefan Kiechl, Christoph Schmidauer, Eva Hametner
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
We present a case with prolonged Lorlatinib-related dyslipidemia causing internal carotid artery stenosis, putting the patient at risk of cerebrovascular events. Through intensified lipid-lowering treatment and dose reduction of Lorlatinib, LDL-C lev
Externí odkaz:
https://doaj.org/article/f0745e621c964c45b51e8c5a0cc2e75b
Autor:
Roberta Granata, Klaus Seppi, Werner Poewe, Federico Carbone, Philipp Ellmerer, Philipp Mahlknecht, Atbin Djamshidian, Sylvia Boesch, Eva Hametner, Anna Hotter, Marcel Ritter, Anna Hussl, Sabine Spielberger
Publikováno v:
Movement Disorders
Background The pathophysiology of cervical dystonia is still unclear. Recent evidence points toward a network disorder affecting several brain areas. The objective of this study was to assess the saccadic inhibition as a marker of corticostriatal fun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2b363048bb3515c5c1c9bf7cca03535
https://doi.org/10.1002/mds.28486
https://doi.org/10.1002/mds.28486
Autor:
Richard Dodel, Matthias Oechsner, Elias Wolf, Daniela Besong-Agbo, Michael Bacher, Werner Poewe, Eva Hametner, Markus Reindl, Carmen Noelker, Frank Jessen, Wolfgang H. Oertel
Publikováno v:
Neurology 80(2), 169-175 (2012). doi:10.1212/WNL.0b013e31827b90d1
Biomarkers are required for the diagnosis and monitoring of disease progression in Parkinson disease (PD). To date, most studies have concentrated on α-synuclein (α-Syn), a protein involved in Parkinson disease pathogenesis, as a potential biomarke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d11d7f558096d7bc954a28308e37bfe4
https://doi.org/10.1212/wnl.0b013e31827b90d1
https://doi.org/10.1212/wnl.0b013e31827b90d1
Autor:
Philipp Mahlknecht, Johannes Rainer, Werner Poewe, Markus Reindl, Christoph Grabmer, Sylvia Stemberger, Gregor K. Wenning, Eva Hametner, Rudolf Kirchmair, Christoph Scherfler, Fabienne Sprenger, Klaus Seppi
Publikováno v:
Proteome Science
Proteome Science, Vol 10, Iss 1, p 71 (2012)
Proteome Science, Vol 10, Iss 1, p 71 (2012)
Background Microarray technology may offer a new opportunity to gain insight into disease-specific global protein expression profiles. The present study was performed to apply a serum antibody microarray to screen for differentially regulated cytokin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fef243a3c3e35c13e4c34c8ca1cec35c
https://pubmed.ncbi.nlm.nih.gov/23173604
https://pubmed.ncbi.nlm.nih.gov/23173604
Autor:
Gabor G. Kovacs, Albrecht Gröner, Alexander Peden, Thomas Ströbel, Regina Katzenschlager, Stefan Koppi, James W. Ironside, Michael Knoflach, Dieter Langenscheidt, Mark Head, Till Voigtländer, Romana Höftberger, Serge Weis, Anna S. Berghoff, Gina Puska, Helen Yull, Armin Muigg, Elisabeth Zaruba, Astrid E. Grams, Hamid Assar, Lajos László, Eva Hametner, Herbert Budka
Publikováno v:
Acta Neuropathologica Communications
Kovacs, G G, Peden, A, Weis, S, Höftberger, R, Berghoff, A S, Yull, H, Ströbel, T, Koppi, S, Katzenschlager, R, Langenscheidt, D, Assar, H, Zaruba, E, Gröner, A, Voigtländer, T, Puska, G, Hametner, E, Grams, A, Muigg, A, Knoflach, M, László, L, Ironside, J W, Head, M W & Budka, H 2013, ' Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP : a new disease entity? ', Acta Neuropathologica Communications, vol. 1, no. 1, pp. 72 . https://doi.org/10.1186/2051-5960-1-72
Kovacs, G G, Peden, A, Weis, S, Höftberger, R, Berghoff, A S, Yull, H, Ströbel, T, Koppi, S, Katzenschlager, R, Langenscheidt, D, Assar, H, Zaruba, E, Gröner, A, Voigtländer, T, Puska, G, Hametner, E, Grams, A, Muigg, A, Knoflach, M, László, L, Ironside, J W, Head, M W & Budka, H 2013, ' Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP : a new disease entity? ', Acta Neuropathologica Communications, vol. 1, no. 1, pp. 72 . https://doi.org/10.1186/2051-5960-1-72
BackgroundHuman prion diseases are a group of rare fatal neurodegenerative conditions with well-developed clinical and neuropathological diagnostic criteria. Recent observations have expanded the spectrum of prion diseases beyond the classically reco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d94e882af915254427b4e0c3fc08193